 |
|
|
| |
Comparison of a Two-Drug Regimen (Dolutegravir/Rilpivirine) to Standard Three-Drug Regimens in Virologically
Suppressed, Treatment Experienced Individuals in the Real World
|
| |
| |
17th European AIDS Conference, November 6-9, 2019, Basel
Reported by Jules Levin
Gerald Pierone1, Kathy L. Schulman2, Jennifer Fusco2, Vani Vannappagari3, Michael Aboud4, Leigh Ragone3, Gregory Fusco2
1Whole Family Health Center, Vero Beach, FL, USA; 2Epividian, Durham, NC, USA; 3ViiV Healthcare, Research Triangle Park, NC, USA; 4ViiV Healthcare, London, United Kingdom
|
| |
|
|
|
|
|
